Latest stories on ZNTL
William Blair initiates Zentalis stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Zentalis initiated with an Outperform at William Blair
The Fly61 · neutralanalyst
Zentalis Pharmaceuticals, Inc. (ZNTL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Zentalis Pharmaceuticals: Data Due H1 '27 Will Clarify Prospects Of Azenosertib
Seeking Alpha56 · neutralproduct/pr
Zentalis 23M share Spot Secondary priced at $3.50
The Fly28 · bearishgeneral
Zentalis Pharmaceuticals, Inc. (ZNTL) files 8-K
SEC 8-K50 · neutralgeneral
Why is Zentalis Pharmaceuticals stock tumbling today?
Investing.com Markets34 · bearishgeneral
Zentalis Pharmaceuticals Shares Fall on Public Offering Pricing
MarketWatch28 · bearishgeneral
Zentalis Pharmaceuticals slides after pricing 23M share public offering at $3.50/share
Seeking Alpha24 · bearishgeneral
Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
GlobeNewswire24 · bearishgeneral
Stocks to watch on Thursday after hours: AMAT, DLO, ZNTL
Seeking Alpha50 · neutralgeneral
Zentalis launches proposed public offering
Seeking Alpha24 · bearishgeneral
Zentalis Pharmaceuticals stock falls on public offering news
Investing.com Markets28 · bearishgeneral
Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
GlobeNewswire28 · bearishgeneral
Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
StockTitan28 · bearishgeneral
Zentalis Price Target Raised To 5 From 4 At Morgan Stanley
The Fly61 · neutralanalyst
Zentalis Sets Eyes on Accelerated Approval as Clinical Milestones Align and Cash Runway Extends into 2027
August 7, 2026
MarketChameleon67 · bullishproduct/pr
Zentalis Pharmaceuticals GAAP EPS of -$0.59 misses by $0.10
Seeking Alpha34 · bearishearnings
Zentalis Reports Q2 Eps 59c Consensus 48c
The Fly67 · bullishearnings
Zentalis Pharmaceuticals, Inc. (ZNTL) files 8-K
SEC 8-K50 · neutralgeneral